OrthoPediatrics Corp. provided preliminary unaudited revenue guidance for the fourth quarter and full year ended December 31, 2021. For the quarter, the company expects revenue to be $24.8 million, up 31%, compared to $18.9 million in the fourth quarter of 2020.

For the full year, the company expects revenue to be $98.0 million, representing annual growth of 38%.